DeviceClearance

CAPTIA MEASLES IGM— 510(k) K140455

Substantially Equivalent

Trinity Biotech USA

FDA 510(k) clearance K140455 for CAPTIA MEASLES IGM, Substantially Equivalent on 2014-05-22. Applicant: Trinity Biotech USA.

Clearance details

Applicant
Trinity Biotech USA
Product code
Code PCL
Advisory panel
Microbiology
Date received
Decision date
Decision
Substantially Equivalent
Clearance type
Traditional
Location
Jamestown, NY, US
Download summary PDFView on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.